TY - JOUR AU - Agiba, Ahmed M. PY - 2017/03/01 Y2 - 2024/03/29 TI - NUTRACEUTICAL FORMULATIONS CONTAINING GLUCOSAMINE AND CHONDROITIN SULPHATE IN THE TREATMENT OF OSTEOARTHRITIS: EMPHASIS ON CLINICAL EFFICACY AND FORMULATION CHALLENGES JF - International Journal of Current Pharmaceutical Research JA - Int J Curr Pharm Sci VL - 9 IS - 2 SE - Review Article(s) DO - 10.22159/ijcpr.2017v9i2.17380 UR - https://journals.innovareacademics.in/index.php/ijcpr/article/view/17380 SP - 1-7 AB - <p>Osteoarthritis (OA) is essentially a debilitating disease symptomatized by a gradual loss of articular joint cartilage, causing painful impairment among the population of different ages, particularly patients over the age of 50 y. Nutraceuticals; namely glucosamine and chondroitin have been widely used in the treatment of OA. The chondroprotective properties of the aforementioned agents have been reported, allowing the repair and recovery of the articular surface in OA. The purpose of this review article is to report the current evidence for the use of glucosamine and chondroitin sulphate in the treatment of knee OA with emphasis on their indications for clinical use, effectiveness and safety. It also highlights the role of some advanced formulation technologies in optimizing the delivery of those drugs.</p><p><strong>Keywords: </strong>Osteoarthritis, Glucosamine, Chondroitin, Clinical use, Formulation technologies</p> ER -